{"gene":"ARID5A","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2013,"finding":"Arid5a is an RNA-binding protein that stabilizes IL-6 mRNA by binding to its 3' untranslated region, counteracting the destabilizing effect of the ribonuclease Regnase-1, thereby promoting elevation of IL-6 serum levels in vivo.","method":"RNA binding assays, Arid5a-deficient mice, LPS challenge model, mRNA stability assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal functional assays in vitro and in vivo KO mice, replicated across multiple contexts","pmids":["23676272"],"is_preprint":false},{"year":2011,"finding":"Arid5a physically interacts with Sox9 in the nucleus, binds directly to the Col2a1 gene promoter, stimulates histone H3 acetylation at that region, and cooperatively enhances chondrocyte-specific transcription and differentiation.","method":"Co-immunoprecipitation, ChIP, overexpression and knockdown in ATDC5 cells, organ culture","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, ChIP, KD/OE with defined phenotype)","pmids":["21346191"],"is_preprint":false},{"year":2016,"finding":"Arid5a selectively stabilizes Stat3 mRNA (but not Stat1 or Stat5 mRNA) in CD4+ T cells in an IL-6-dependent manner, directing naive CD4+ T cells toward Th17 differentiation; loss of Arid5a reduces STAT3 levels and shifts cells toward IL-10-expressing anti-inflammatory fate.","method":"Arid5a-deficient mice, mRNA stability assays, Th17 polarization assays, flow cytometry","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — KO with defined molecular and cellular phenotype, selective mRNA target specificity demonstrated","pmids":["27022145"],"is_preprint":false},{"year":2016,"finding":"Arid5a binds to a conserved stem-loop structure in the 3'UTR of T-bet mRNA and stabilizes it in Th1 cells, thereby promoting IFN-γ production and contributing to septic shock; Arid5a-deficient mice are resistant to LPS-induced endotoxic shock with reduced IFN-γ and IL-6.","method":"RNA binding assays (stem-loop structure), Arid5a KO mice, LPS/P. acnes endotoxic shock models, cytokine measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct RNA binding to defined structural element, in vivo KO phenotype","pmids":["27671645"],"is_preprint":false},{"year":2017,"finding":"During LPS stimulation, NF-κB activates Arid5a gene expression (promoting IL-6 mRNA stabilization), while in the late phase p38 MAPK phosphorylates Arid5a and recruits the E3 ubiquitin ligase WWP1, which ubiquitinates Arid5a via K48-linked chains leading to its proteasomal degradation; additionally, AUF-1 destabilizes Arid5a mRNA via AU-rich elements in its 3'UTR.","method":"Phosphorylation assays, ubiquitination assays, NF-κB/MAPK pathway inhibitors, mutagenesis blocking phosphorylation, mRNA stability assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 — multiple PTM mechanisms identified with functional validation including mutagenesis","pmids":["28168301"],"is_preprint":false},{"year":2018,"finding":"IL-17 signaling induces Arid5a expression; Arid5a is recruited to the adaptor TRAF2, stabilizes IL-17-induced cytokine transcripts by binding their 3'UTRs, counteracts MCPIP1 (Regnase-1)-mediated mRNA degradation, and associates with the eukaryotic translation initiation complex to facilitate translation of the transcription factors IκBζ and C/EBPβ, creating a feed-forward amplification loop.","method":"Co-immunoprecipitation (TRAF2, eIF complex), mRNA stability assays, translation assays, Arid5a KO cells","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying distinct mechanisms (mRNA stability + translation + protein complex)","pmids":["30301788"],"is_preprint":false},{"year":2018,"finding":"Arid5a stabilizes OX40 mRNA in CD4+ T cells by recognizing an alternative decay element (ADE)-like stem-loop structure in the OX40 3'UTR, and impairs the RNA-destabilizing functions of both Regnase-1 and Roquin-1 on this target.","method":"RNA binding assays, stem-loop mutagenesis, Arid5a KO mice, EAE model, adoptive transfer","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct RNA binding to defined structural element, multiple functional assays, in vivo validation","pmids":["29244194"],"is_preprint":false},{"year":2018,"finding":"Arid5a is present in both cytoplasm and nucleus of resting cells; upon inflammatory stimulation it is imported into the nucleus via the classical importin-α/β1 pathway, and subsequently exported to the cytoplasm via CRM1-dependent nuclear export; cytoplasmic Arid5a is associated with UPF1 (up-frameshift protein 1). This stimulus-dependent nuclear-cytoplasmic shuttling is required for its dual function in mRNA stabilization and transcriptional regulation.","method":"Transgenic mice, nuclear fractionation, importin pathway inhibitors (importazole), CRM1 inhibitor (leptomycin B), co-immunoprecipitation with UPF1","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization experiments with defined pathway components and functional consequence","pmids":["29358370"],"is_preprint":false},{"year":2019,"finding":"Arid5a represses transcription of Ppar-γ2, acting as a negative regulator of adipogenesis; in the absence of Arid5a, persistent Ppar-γ2 expression drives adipocyte differentiation and enhanced fatty acid uptake. Arid5a and Ppar-γ2 are dynamically counter-regulated by each other to maintain adipose tissue homeostasis.","method":"Arid5a KO mice (adult-onset obesity), Arid5a transgenic mice (diet-induced obesity resistance), 3T3-L1 differentiation assays, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — KO and transgenic models with defined molecular mechanism, replicated in vitro and in vivo","pmids":["31289228"],"is_preprint":false},{"year":2021,"finding":"Arid5a stabilizes Ido1 (indoleamine 2,3-dioxygenase 1) and Ccl2 mRNAs in tumor cells, augmenting tryptophan catabolism and creating an immunosuppressive tumor microenvironment that promotes immune evasion; deletion of Arid5a in tumor cells enhances antitumor immunity in immunocompetent but not immunodeficient mice.","method":"Arid5a KO tumor cell lines, mRNA stability assays, syngeneic mouse tumor models, immune cell profiling","journal":"Cancer immunology research","confidence":"High","confidence_rationale":"Tier 2 — KO with defined molecular targets and in vivo immune phenotype","pmids":["34006522"],"is_preprint":false},{"year":2021,"finding":"IL-6-induced Arid5a promotes transcription of the lncRNA AU021063, which in turn stabilizes Trib3 and activates Mek/Erk signaling to drive breast cancer metastasis; genetic ablation of Arid5a abolishes this cascade.","method":"Arid5a KO, RNA stability assays, in vitro invasion assays, mouse metastasis models","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — defined pathway but single lab, mechanism partly indirect via lncRNA intermediate","pmids":["34389433"],"is_preprint":false},{"year":2005,"finding":"MRF1 (ARID5A) binds to both the N-terminal and C-terminal regions of ERα in an estradiol-independent manner (also interacts with thyroid receptor α, RXRα, and androgen receptor in ligand-dependent manner), has intrinsic repressor activity, and represses ERα-mediated transcriptional activation in a dose-dependent manner without requiring histone deacetylase activity.","method":"Yeast two-hybrid screen, co-immunoprecipitation, recombinant protein binding assays, transient transfection reporter assays, GAL4 reporter assay","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding confirmed by multiple methods, functional repression validated","pmids":["15941852"],"is_preprint":false},{"year":2014,"finding":"ARID5A is induced by IL-6 in CD4+ T cells via a STAT3-dependent mechanism; ARID5A physically associates with RORγt through its N-terminal region and acts as a negative regulator of RORγt-induced Th17 cell differentiation and IL-17A promoter activation.","method":"Co-immunoprecipitation, overexpression in murine CD4+ T cells, IL-17A promoter reporter assay, flow cytometry","journal":"Arthritis & rheumatology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP with functional reporter assay, single lab","pmids":["24782182"],"is_preprint":false},{"year":2020,"finding":"Noncanonical phosphorylation of STAT1 at Thr749 (mediated by a TBK1-IKKβ complex downstream of TLR4 endocytosis) drives STAT1 binding to a noncanonical DNA motif (5'-TTTGANNC-3') in the ARID5A promoter, thereby activating ARID5A expression and downstream IL-6 mRNA stabilization.","method":"Site-specific mutagenesis, ChIP, kinase inhibitors, TLR4 endocytosis manipulation, ARID5A promoter reporter assays","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis, ChIP, and functional reporter assays define a novel upstream regulatory mechanism","pmids":["32209697"],"is_preprint":false},{"year":2020,"finding":"β-catenin-mediated transcriptional activation of FOSL2 and repression of ARID5A together drive M1-to-M2 TAM polarization in lung cancer; pharmacological or genetic ablation of β-catenin reprograms M2-like TAMs to M1-like TAMs and suppresses tumor growth.","method":"Pharmacological β-catenin inhibition, macrophage-specific genetic ablation, transcriptome analysis, in vitro TAM model, in vivo lung tumor models","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological manipulation with defined pathway, but ARID5A is one of multiple effectors","pmids":["32548260"],"is_preprint":false},{"year":2024,"finding":"Using NMR-centered biochemistry, the Arid5a ARID domain was found to bind DNA with a defined preference; high-throughput in vitro binding defined a consensus RNA-binding motif engaged by the core ARID domain; iCLIP2 revealed transcriptome-wide binding preference for (A)U-rich regions in pre-mRNA transcripts; intrinsically disordered regions (IDRs) flanking the ARID domain modulate DNA-binding specificity and affinity, and are crucial for RNA interactions.","method":"NMR spectroscopy, high-throughput in vitro binding (RBNS), iCLIP2, mutagenesis of IDR extensions","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure, in vitro binding, transcriptome-wide mapping, and mutagenesis in one study","pmids":["38866324"],"is_preprint":false},{"year":2024,"finding":"ARID5A stabilizes IDO1 mRNA in colorectal cancer cells, leading to upregulation of IDO1 expression, tryptophan-to-kynurenine conversion, kynurenine-mediated AhR activation in CAR-T cells, and consequent CAR-T cell exhaustion; targeting the ARID5A-IDO1-AhR axis with AhR or IDO1 inhibitors alleviates T cell exhaustion.","method":"ARID5A overexpression, mRNA stability assays, CAR-T co-culture assays, AhR/IDO1 inhibitor treatment","journal":"Translational oncology","confidence":"Medium","confidence_rationale":"Tier 3 — defined mechanistic axis but single lab, limited orthogonal validation","pmids":["38316094"],"is_preprint":false},{"year":2024,"finding":"Transcriptome-wide RIP-Seq revealed that Arid5a inducibly interacts with IL-17 target mRNAs including CEBPB and CEBPD, as well as rRNAs including 18S rRNA (a 40S ribosome constituent); IL-17 promotes Arid5a nuclear export and association with 18S rRNA; Arid5a-deficient cells show repressed global protein synthesis, with C/EBPs controlled at the translational rather than mRNA level, establishing Arid5a as a ribosome-associated translational regulator.","method":"RIP-Seq, Arid5a KO mice, AGN mouse model, fractionation, polysome profiling, CRISPR-Cas9 KO","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — transcriptome-wide RIP-Seq plus functional KO phenotype and mechanistic validation of ribosome association","pmids":["39058386"],"is_preprint":false},{"year":2025,"finding":"ARID5A epi-transcriptionally stabilizes MAVS (Mitochondrial Antiviral Signaling Protein) mRNA in cardiomyocytes of aged hearts, leading to NF-κB and TBK1 activation and amplifying cardiac aging and inflammation; lentiviral shRNA targeting ARID5A in aged mouse myocardium mitigated inflammatory and aging phenotypes and improved cardiac function.","method":"Single-cell RNA-seq of human heart tissues, ARID5A-MAVS RNA binding/stability assays, lentiviral shRNA gene therapy in aged mice, NF-κB/TBK1 pathway analysis","journal":"Nature cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 — defined mRNA target with in vivo gene therapy validation, multiple methods","pmids":["40301689"],"is_preprint":false},{"year":2025,"finding":"In skeletal muscle, Arid5a functions as a transcriptional repressor of the lipid uptake genes Cd36 and Fabp4, downstream of glucocorticoid receptor (GR) transactivation; Arid5a is required and sufficient to reduce muscle triacylglycerol accumulation, acting as a pro-metabolic effector.","method":"GR knock-in mice (rs6190), myotropic AAV overexpression/knockdown in muscle, RNA-seq and ChIP-seq, metabolic phenotyping","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo AAV KD/OE with defined transcriptional targets and metabolic phenotype, single lab","pmids":["40632872"],"is_preprint":false},{"year":2026,"finding":"TNF upregulates Arid5a expression through the NF-κB1/TRAF2 pathway, causing cytoplasmic relocalization of Arid5a; Arid5a then stabilizes proinflammatory transcripts and enhances expression of chemokines driving rheumatoid arthritis; Arid5a-deficient mice are resistant to collagen-induced arthritis with reduced Th17 cells in synovial tissue.","method":"TRAF2 KO cells, NF-κB/IKK inhibitors, NIK inhibitors, Arid5a KO mice, collagen-induced arthritis model, mRNA stability assays","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — defined upstream pathway (TRAF2/NF-κB1), functional KO in two disease-relevant contexts","pmids":["41574607"],"is_preprint":false},{"year":2022,"finding":"Rbpjl binds to the promoter region of Arid5a and transcriptionally represses its expression, thereby suppressing the Arid5a/IL-6/STAT3 signaling axis and alleviating pancreatic acinar cell inflammation in acute pancreatitis.","method":"ChIP, EMSA, dual-luciferase reporter assays, Rbpjl overexpression/knockdown, LPS-induced cell model, cerulein-induced AP mouse model","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct DNA binding of Rbpjl to Arid5a promoter confirmed by ChIP/EMSA/reporter, functional in vivo validation","pmids":["35725649"],"is_preprint":false},{"year":2020,"finding":"β2-adrenergic receptor stimulation activates the cAMP/PKA/CREB pathway in cardiac fibroblasts, phosphorylating CREB and inducing Arid5a expression; Arid5a in turn stabilizes IL-6 mRNA, and this pathway is required for β2AR-mediated IL-6 production (abolished in Arid5a KO cardiac fibroblasts).","method":"Arid5a KO cardiac fibroblasts, β2AR agonists, adenylate cyclase activators, PKA inhibitors, CREB activity assays, ELISA","journal":"Pharmacology research & perspectives","confidence":"Medium","confidence_rationale":"Tier 2 — KO fibroblasts with defined upstream pathway, single lab","pmids":["32302067"],"is_preprint":false}],"current_model":"ARID5A is a bifunctional nucleic acid-binding protein that, upon inflammatory stimulation, shuttles from the nucleus to the cytoplasm (via importin-α/β1 import and CRM1-dependent export) where its ARID domain — extended by intrinsically disordered regions — binds AU-rich 3'UTR stem-loop structures to stabilize key proinflammatory mRNAs (IL-6, STAT3, T-bet, OX40, IDO1, MAVS, and others), counteracts Regnase-1/Roquin-mediated mRNA decay, associates with 18S rRNA to promote translation of targets including C/EBPβ and C/EBPδ, and is regulated by NF-κB (transcriptional induction), p38 MAPK–WWP1 (K48-ubiquitination and degradation), and AUF-1 (mRNA destabilization), while in the nucleus it acts as a transcriptional co-activator (with Sox9 at Col2a1) or repressor (of Ppar-γ2, Cd36, Fabp4) depending on cellular context."},"narrative":{"teleology":[{"year":2005,"claim":"Before its RNA-binding role was recognized, ARID5A (MRF1) was identified as a nuclear receptor corepressor, establishing that it directly interacts with ERα and other nuclear receptors to repress transcription independently of HDACs.","evidence":"Yeast two-hybrid, co-IP, and reporter assays in transfected cells","pmids":["15941852"],"confidence":"High","gaps":["Endogenous target genes of the ERα–ARID5A repressor complex were not identified","In vivo relevance of nuclear receptor corepression was not tested"]},{"year":2011,"claim":"Discovery of ARID5A as a transcriptional co-activator of Sox9 at the Col2a1 promoter revealed that its nuclear function is context-dependent—activating or repressing transcription depending on partner factors.","evidence":"Co-IP with Sox9, ChIP at Col2a1, overexpression/knockdown in ATDC5 chondrocytes","pmids":["21346191"],"confidence":"High","gaps":["Whether ARID5A binds Col2a1 DNA directly via its ARID domain or is recruited indirectly through Sox9 was not resolved","Genome-wide transcriptional co-activator targets in chondrocytes were not mapped"]},{"year":2013,"claim":"The landmark finding that ARID5A stabilizes IL-6 mRNA by binding its 3′UTR and antagonizing Regnase-1 reframed the protein as a post-transcriptional immune regulator, explaining its requirement for elevated IL-6 during endotoxemia.","evidence":"RNA binding assays, Arid5a-deficient mice, LPS challenge, mRNA stability assays","pmids":["23676272"],"confidence":"High","gaps":["Structural basis of the 3′UTR interaction was unknown","Full repertoire of stabilized mRNAs remained undefined"]},{"year":2016,"claim":"Extension of the mRNA stabilization paradigm to STAT3 and T-bet mRNAs demonstrated that ARID5A selectively governs Th17 and Th1 differentiation programs by stabilizing lineage-defining transcription factor transcripts.","evidence":"Arid5a KO Th17/Th1 polarization assays, stem-loop binding, LPS/P. acnes septic shock models","pmids":["27022145","27671645"],"confidence":"High","gaps":["How ARID5A discriminates STAT3 from STAT1/STAT5 mRNAs at the structural level was not defined","Relative contribution of Th17 vs Th1 arm in autoimmunity was unresolved"]},{"year":2017,"claim":"Identification of the NF-κB–driven induction and p38 MAPK/WWP1-mediated K48-ubiquitination of ARID5A established the negative feedback loop that terminates its activity during the late phase of inflammation.","evidence":"Phosphorylation/ubiquitination assays, mutagenesis, NF-κB/MAPK inhibitors, AUF-1 mRNA decay","pmids":["28168301"],"confidence":"High","gaps":["Specific p38-phosphorylated residues on ARID5A were not mapped at single-site resolution","Whether other E3 ligases contribute to ARID5A turnover was not tested"]},{"year":2018,"claim":"Three simultaneous advances broadened ARID5A's mechanism: (i) nuclear–cytoplasmic shuttling via importin-α/β1 and CRM1 was shown to be required for its dual functions; (ii) OX40 mRNA was identified as a target stabilized against both Regnase-1 and Roquin; (iii) ARID5A was found to associate with the translation initiation machinery to promote C/EBPβ translation downstream of IL-17.","evidence":"Importin/CRM1 inhibitors in transgenic mice; stem-loop mutagenesis and EAE model; TRAF2 co-IP and polysome association","pmids":["29358370","29244194","30301788"],"confidence":"High","gaps":["How ARID5A engages the translation initiation complex mechanistically (direct vs indirect) was not resolved","Identity of UPF1 interaction's functional consequence remained unclear"]},{"year":2019,"claim":"Demonstration that ARID5A represses PPARγ2 transcription to restrain adipogenesis extended its nuclear repressor function to metabolic homeostasis, with knockout mice developing adult-onset obesity.","evidence":"Arid5a KO (obesity) and transgenic (obesity resistance) mice, 3T3-L1 differentiation","pmids":["31289228"],"confidence":"High","gaps":["Whether ARID5A directly binds PPARγ2 regulatory DNA or acts through a cofactor complex was not determined","Interaction with chromatin-modifying enzymes at adipogenic loci was not addressed"]},{"year":2020,"claim":"Upstream regulation of ARID5A was further defined: noncanonical pSTAT1-Thr749 binds a novel motif in the ARID5A promoter downstream of TLR4 endocytosis, and β2-adrenergic/CREB signaling induces ARID5A in cardiac fibroblasts, revealing tissue-specific transcriptional control.","evidence":"ChIP, site-directed mutagenesis, ARID5A promoter reporters; β2AR agonists and PKA inhibitors in Arid5a KO fibroblasts","pmids":["32209697","32302067"],"confidence":"High","gaps":["Whether pSTAT1-Thr749 and NF-κB cooperate at the ARID5A promoter simultaneously was not tested","In vivo cardiac phenotype of ARID5A induction via β2AR was not examined"]},{"year":2021,"claim":"ARID5A's role in tumor immune evasion was established: it stabilizes IDO1 and CCL2 mRNAs in tumor cells, promoting tryptophan catabolism and immunosuppression; separately, it activates transcription of a lncRNA driving breast cancer metastasis.","evidence":"Arid5a KO tumor lines in syngeneic models with immune profiling; Arid5a KO with metastasis assays","pmids":["34006522","34389433"],"confidence":"High","gaps":["Whether ARID5A's mRNA stabilization vs transcriptional activation roles can be pharmacologically uncoupled was not explored","Generalizability across cancer types beyond melanoma, colon, and breast was not tested"]},{"year":2024,"claim":"Structural and transcriptome-wide studies resolved how ARID5A recognizes nucleic acids: NMR defined ARID domain–DNA contacts, RBNS/iCLIP2 identified a consensus AU-rich RNA motif, and IDRs flanking the ARID domain were shown to be essential for RNA binding; simultaneously, RIP-Seq and polysome profiling established ARID5A as a ribosome-associated translational regulator via 18S rRNA interaction.","evidence":"NMR, RBNS, iCLIP2, IDR mutagenesis; RIP-Seq, polysome profiling in Arid5a KO mice","pmids":["38866324","39058386"],"confidence":"High","gaps":["Atomic-resolution structure of ARID5A bound to an RNA stem-loop is still lacking","How 18S rRNA association promotes translation of specific mRNAs over others is mechanistically unresolved"]},{"year":2025,"claim":"ARID5A's target repertoire was extended to cardiac aging (MAVS mRNA stabilization) and skeletal muscle lipid metabolism (transcriptional repression of CD36/FABP4), demonstrating that its dual nuclear/cytoplasmic functions operate across diverse non-immune tissues.","evidence":"scRNA-seq of human hearts, ARID5A shRNA gene therapy in aged mice; GR knock-in mice, myotropic AAV OE/KD with ChIP-seq","pmids":["40301689","40632872"],"confidence":"High","gaps":["Whether ARID5A-MAVS stabilization contributes to non-cardiac aging tissues remains untested","Structural basis of ARID5A's dual DNA-repressor vs mRNA-stabilizer selectivity is undefined"]},{"year":null,"claim":"Key unresolved questions include the atomic structure of ARID5A in complex with RNA stem-loops, the mechanism by which ribosome association selectively enhances translation of specific targets, and whether the transcriptional and post-transcriptional functions can be pharmacologically dissected for therapeutic intervention.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution co-crystal or cryo-EM structure of ARID5A bound to RNA","Selectivity mechanism for ribosome-associated translational enhancement is unknown","No small-molecule inhibitors of ARID5A have been reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,2,3,5,6,9,15,16,17,18]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,8,15,19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,8,11,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,17]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[5,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,7,8,11,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,7,17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,3,6,9,20]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,8,10,11,19]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,2,3,5,15,17,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,13,14,22]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[8,9,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1]}],"complexes":[],"partners":["REGNASE1","SOX9","WWP1","TRAF2","UPF1","ROQUIN1","ESRA","RORGC"],"other_free_text":[]},"mechanistic_narrative":"ARID5A is a bifunctional nucleic acid-binding protein that acts as both a post-transcriptional regulator of proinflammatory and metabolic mRNAs and a context-dependent transcriptional co-activator or repressor. In the cytoplasm, the ARID domain—extended by intrinsically disordered regions—recognizes AU-rich stem-loop structures in the 3′UTRs of target mRNAs (IL-6, STAT3, T-bet, OX40, IDO1, MAVS), stabilizing them against Regnase-1- and Roquin-mediated decay, and associates with 18S rRNA to promote translation of targets such as C/EBPβ and C/EBPδ [PMID:23676272, PMID:27022145, PMID:27671645, PMID:29244194, PMID:39058386, PMID:40301689]. In the nucleus, ARID5A cooperates with Sox9 to activate Col2a1 transcription in chondrocytes and represses PPARγ2, CD36, and FABP4 to restrain adipogenesis and muscle lipid uptake [PMID:21346191, PMID:31289228, PMID:40632872]. ARID5A expression is induced by NF-κB, noncanonical pSTAT1, and CREB, while its turnover is governed by p38 MAPK-dependent phosphorylation and WWP1-mediated K48-linked ubiquitination; stimulus-dependent nuclear–cytoplasmic shuttling via importin-α/β1 import and CRM1-dependent export enables its dual functions [PMID:28168301, PMID:29358370, PMID:32209697]."},"prefetch_data":{"uniprot":{"accession":"Q03989","full_name":"AT-rich interactive domain-containing protein 5A","aliases":["Modulator recognition factor 1","MRF-1"],"length_aa":594,"mass_kda":64.1,"function":"DNA-binding protein that may regulate transcription and act as a repressor by binding to AT-rich stretches in the promoter region of target genes (PubMed:8649988). May positively regulate chondrocyte-specific transcription such as of COL2A1 in collaboration with SOX9 and positively regulate histone H3 acetylation at chondrocyte-specific genes. May stimulate early-stage chondrocyte differentiation and inhibit later stage differention (By similarity). Can repress ESR1-mediated transcriptional activation; proposed to act as corepressor for selective nuclear hormone receptors (PubMed:15941852). As an RNA-binding protein, involved in the regulation of inflammatory response by stabilizing selective inflammation-related mRNAs, such as STAT3 and TBX21 (By similarity). Also stabilizes IL6 mRNA (PubMed:32209697). Binds to stem loop structures located in the 3'UTRs of IL6, STAT3 and TBX21 mRNAs; at least for STAT3 prevents binding of ZC3H12A to the mRNA stem loop structure thus inhibiting its degradation activity. Contributes to elevated IL6 levels possibly implicated in autoimmunity processes. IL6-dependent stabilization of STAT3 mRNA may promote differentiation of naive CD4+ T-cells into T-helper Th17 cells. In CD4+ T-cells may also inhibit RORC-induced Th17 cell differentiation independently of IL6 signaling. Stabilization of TBX21 mRNA contributes to elevated interferon-gamma secretion in Th1 cells possibly implicated in the establishment of septic shock (By similarity). Stabilizes TNFRSF4/OX40 mRNA by binding to the conserved stem loop structure in its 3'UTR; thereby competing with the mRNA-destabilizing functions of RC3H1 and endoribonuclease ZC3H12A (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q03989/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARID5A","classification":"Not Classified","n_dependent_lines":82,"n_total_lines":1208,"dependency_fraction":0.06788079470198675},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ARID5A","total_profiled":1310},"omim":[{"mim_id":"612457","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B; ARID3B","url":"https://www.omim.org/entry/612457"},{"mim_id":"611583","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A; ARID5A","url":"https://www.omim.org/entry/611583"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"blood vessel","ntpm":78.7}],"url":"https://www.proteinatlas.org/search/ARID5A"},"hgnc":{"alias_symbol":["MRF-1","RP11-363D14"],"prev_symbol":[]},"alphafold":{"accession":"Q03989","domains":[{"cath_id":"1.10.150.60","chopping":"80-151","consensus_level":"medium","plddt":87.8067,"start":80,"end":151}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03989","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q03989-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q03989-F1-predicted_aligned_error_v6.png","plddt_mean":54.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARID5A","jax_strain_url":"https://www.jax.org/strain/search?query=ARID5A"},"sequence":{"accession":"Q03989","fasta_url":"https://rest.uniprot.org/uniprotkb/Q03989.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q03989/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03989"}},"corpus_meta":[{"pmid":"23676272","id":"PMC_23676272","title":"Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23676272","citation_count":180,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32548260","id":"PMC_32548260","title":"Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32548260","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28168301","id":"PMC_28168301","title":"TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28168301","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27022145","id":"PMC_27022145","title":"Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27022145","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30301788","id":"PMC_30301788","title":"IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30301788","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9698327","id":"PMC_9698327","title":"Upregulation of a new microglial gene, mrf-1, in response to programmed neuronal cell death and degeneration.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9698327","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27671645","id":"PMC_27671645","title":"Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27671645","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21346191","id":"PMC_21346191","title":"Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21346191","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29358370","id":"PMC_29358370","title":"Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29358370","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32035762","id":"PMC_32035762","title":"Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity.","date":"2020","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32035762","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29244194","id":"PMC_29244194","title":"Arid5a stabilizes OX40 mRNA in murine CD4+ T cells by recognizing a stem-loop structure in its 3'UTR.","date":"2018","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29244194","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31867000","id":"PMC_31867000","title":"Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31867000","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34389433","id":"PMC_34389433","title":"The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34389433","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31289228","id":"PMC_31289228","title":"Feedback regulation of Arid5a and Ppar-γ2 maintains adipose tissue homeostasis.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31289228","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34006522","id":"PMC_34006522","title":"Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression.","date":"2021","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34006522","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29701145","id":"PMC_29701145","title":"A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression.","date":"2018","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/29701145","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32302067","id":"PMC_32302067","title":"β2-adrenergic stimulation induces interleukin-6 by increasing Arid5a, a stabilizer of mRNA, through cAMP/PKA/CREB pathway in cardiac fibroblasts.","date":"2020","source":"Pharmacology research & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/32302067","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12363408","id":"PMC_12363408","title":"ATP selectively suppresses the synthesis of the inflammatory protein microglial response factor (MRF)-1 through Ca(2+) influx via P2X(7) receptors in cultured microglia.","date":"2002","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12363408","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28379390","id":"PMC_28379390","title":"Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury.","date":"2017","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28379390","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8265342","id":"PMC_8265342","title":"Single point mutations in domain II of the yeast mitochondrial release factor mRF-1 affect ribosome binding.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8265342","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35126382","id":"PMC_35126382","title":"Recent Advances in the Role of Arid5a in Immune Diseases and Cancer.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35126382","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33424253","id":"PMC_33424253","title":"Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis.","date":"2020","source":"Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","url":"https://pubmed.ncbi.nlm.nih.gov/33424253","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12420315","id":"PMC_12420315","title":"Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia.","date":"2002","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/12420315","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37396543","id":"PMC_37396543","title":"The emerging role of Arid5a in cancer: A new target for tumors.","date":"2022","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37396543","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38866324","id":"PMC_38866324","title":"Arid5a uses disordered extensions of its core ARID domain for distinct DNA- and RNA-recognition and gene regulation.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38866324","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38316094","id":"PMC_38316094","title":"ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer.","date":"2024","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38316094","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7527040","id":"PMC_7527040","title":"Isolation and characterization of MRF-1, a brain-derived DNA-binding protein with a capacity to regulate expression of myelin basic protein gene.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7527040","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35725649","id":"PMC_35725649","title":"Blockade of the Arid5a/IL-6/STAT3 axis underlies the anti-inflammatory effect of Rbpjl in acute pancreatitis.","date":"2022","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/35725649","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35940634","id":"PMC_35940634","title":"Arid5a Mediates an IL-17-Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense.","date":"2022","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/35940634","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39058386","id":"PMC_39058386","title":"The RNA binding protein Arid5a drives IL-17-dependent autoantibody-induced glomerulonephritis.","date":"2024","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39058386","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40301689","id":"PMC_40301689","title":"ARID5A orchestrates cardiac aging and inflammation through MAVS mRNA stabilization.","date":"2025","source":"Nature cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/40301689","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36454447","id":"PMC_36454447","title":"RAGE deficiency ameliorates autoimmune hepatitis involving inhibition of IL-6 production via suppressing protein Arid5a in mice.","date":"2022","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36454447","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38044094","id":"PMC_38044094","title":"Arid5a/IL-6/PAI-1 Signaling Is Involved in the Pathogenesis of Lipopolysaccharide-Induced Kidney Injury.","date":"2023","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/38044094","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30301789","id":"PMC_30301789","title":"Arid5a makes the IL-17A/F-responsive pathway less arid.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30301789","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18517291","id":"PMC_18517291","title":"Microglial Response Factor (MRF)-1: Constitutive Expression in Ramified Microglia and Upregulation upon Neuronal Death Induced by Ischemia or Glutamate Exposure.","date":"2000","source":"Zoological science","url":"https://pubmed.ncbi.nlm.nih.gov/18517291","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34158281","id":"PMC_34158281","title":"Arid5a: A Missing Link between EMT and Tumoral Immune Resistance.","date":"2021","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34158281","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40632872","id":"PMC_40632872","title":"The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40632872","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40435618","id":"PMC_40435618","title":"Exosome encapsulated miRNA let-7d-3p mediated Zearalenone-induced hepatotoxicity with Arid5a/STAT3 signaling pathway.","date":"2025","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/40435618","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37129704","id":"PMC_37129704","title":"1H, 13C, 15N backbone chemical shift assignments of the extended ARID domain in human AT-rich interactive domain protein 5a (Arid5a).","date":"2023","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/37129704","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41574607","id":"PMC_41574607","title":"The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritis.","date":"2026","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/41574607","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38585940","id":"PMC_38585940","title":"The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel pro-metabolic targets of the glucocorticoid receptor in muscle.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38585940","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18854154","id":"PMC_18854154","title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18854154","citation_count":787,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12975309","id":"PMC_12975309","title":"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.","date":"2003","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/12975309","citation_count":285,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15640446","id":"PMC_15640446","title":"DNA-binding properties of ARID family proteins.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15640446","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30021884","id":"PMC_30021884","title":"Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei.","date":"2018","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/30021884","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8649988","id":"PMC_8649988","title":"Repression by a differentiation-specific factor of the human cytomegalovirus enhancer.","date":"1996","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8649988","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24981860","id":"PMC_24981860","title":"Human-chromatin-related protein interactions identify a demethylase complex required for chromosome segregation.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24981860","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25814554","id":"PMC_25814554","title":"Phospho-tyrosine dependent protein-protein interaction network.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25814554","citation_count":61,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21184583","id":"PMC_21184583","title":"Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21184583","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32209697","id":"PMC_32209697","title":"Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production.","date":"2020","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/32209697","citation_count":38,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24782182","id":"PMC_24782182","title":"AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.","date":"2014","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24782182","citation_count":37,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34373451","id":"PMC_34373451","title":"Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34373451","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15941852","id":"PMC_15941852","title":"Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha.","date":"2005","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15941852","citation_count":24,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36724073","id":"PMC_36724073","title":"Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36724073","citation_count":20,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23275563","id":"PMC_23275563","title":"Development and application of a DNA microarray-based yeast two-hybrid system.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23275563","citation_count":16,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29044508","id":"PMC_29044508","title":"Differentially regulated gene expression in quiescence versus senescence and identification of ARID5A as a quiescence associated marker.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29044508","citation_count":9,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"40593736","id":"PMC_40593736","title":"Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40593736","citation_count":2,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"41475341","id":"PMC_41475341","title":"Centrosome clustering in cancer cells requires microtubule assembly through a RanGTP-dependent TPX2-KIFC1 interaction.","date":"2025","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/41475341","citation_count":0,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20350,"output_tokens":4470,"usd":0.06405},"stage2":{"model":"claude-opus-4-6","input_tokens":7992,"output_tokens":3574,"usd":0.193965},"total_usd":0.556542,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":31413,"output_tokens":5729,"usd":0.090087},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9652,"output_tokens":3628,"usd":0.20844}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"Arid5a is an RNA-binding protein that stabilizes IL-6 mRNA (but not TNF-α mRNA) by binding to the 3' untranslated region of IL-6 mRNA, and counteracts the destabilizing effect of the endoribonuclease Regnase-1 on IL-6 mRNA.\",\n      \"method\": \"RNA binding assays, mRNA stability assays, Arid5a-deficient mice, LPS stimulation of macrophages\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO mice, RNA binding, mRNA stability assay), replicated across multiple subsequent studies, 180 citations\",\n      \"pmids\": [\"23676272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"During LPS stimulation, NF-κB and an IL-6 positive feedback loop activate Arid5a gene expression. Subsequently, MKP-1 promotes nuclear-to-cytoplasmic translocation of AUF-1, which destabilizes Arid5a mRNA by binding AU-rich elements in its 3' UTR. In the late phase, p38 MAPK phosphorylates Arid5a and recruits WWP1 E3 ubiquitin ligase, which ubiquitinates Arid5a via K48-linked chains leading to its proteasomal degradation.\",\n      \"method\": \"Co-IP, phosphorylation assays, ubiquitination assays, mRNA stability assays, reporter assays, inhibitor treatments in macrophages\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, ubiquitination assays, phosphorylation assays, mRNA stability) in a single comprehensive study\",\n      \"pmids\": [\"28168301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arid5a in T cells selectively stabilizes Stat3 mRNA (but not Stat1 or Stat5 mRNA) through binding to its 3'UTR in an IL-6-dependent manner, thereby directing naive CD4+ T cell differentiation toward Th17 cells.\",\n      \"method\": \"Arid5a-deficient T cells, mRNA stability assays, RNA binding assays, T cell differentiation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype plus direct mRNA stability assays, moderate evidence\",\n      \"pmids\": [\"27022145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arid5a binds to the conserved stem-loop structure in the 3'UTR of T-bet mRNA and stabilizes it, resulting in elevated IFN-γ production in Th1 cells and contributing to septic shock.\",\n      \"method\": \"RNA binding assays, mRNA stability assays, Arid5a KO mice, LPS-induced endotoxic shock model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding demonstrated with structural element defined, KO mice with specific cytokine phenotype\",\n      \"pmids\": [\"27671645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-17 signaling induces Arid5a expression; Arid5a is recruited to the adaptor TRAF2, stabilizes IL-17-induced cytokine mRNAs via 3'UTR binding, counteracts MCPIP1/Regnase-1-mediated mRNA degradation, and inducibly associates with the eukaryotic translation initiation complex to facilitate translation of the transcription factors IκBζ (Nfkbiz) and C/EBPβ (Cebpb).\",\n      \"method\": \"Co-IP (Arid5a-TRAF2 and Arid5a-eIF complex), mRNA stability assays, translation assays, reporter assays, KD experiments\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods: Co-IP, mRNA stability, translation assays, functional KD with defined pathway\",\n      \"pmids\": [\"30301788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Arid5a is found in both the cytoplasm and nucleus under basal conditions and translocates to the cytoplasm upon inflammatory stimulation. Nuclear import occurs via a classical importin-α/β1-mediated pathway, and nuclear export is regulated by the export receptor CRM1. Arid5a associates with UPF1 in the nucleus.\",\n      \"method\": \"Arid5a transgenic mice, nuclear fractionation, inhibitor studies (importin/CRM1 inhibitors), Co-IP with UPF1, live imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation with functional consequence, Co-IP, pharmacological inhibitors of nuclear transport pathways\",\n      \"pmids\": [\"29358370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Arid5a stabilizes OX40 mRNA in CD4+ T cells by recognizing an alternative decay element (ADE)-like stem-loop structure in the OX40 3'UTR, and impairs the RNA-destabilizing functions of both Regnase-1 and Roquin-1 on this stem-loop.\",\n      \"method\": \"mRNA stability assays, RNA binding assays, Arid5a KO mice, EAE model, adoptive transfer experiments\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — structural element defined in 3'UTR, multiple functional assays (stability, KO, in vivo model)\",\n      \"pmids\": [\"29244194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Arid5a physically interacts with the transcription factor Sox9 in the nucleus, co-activates the Col2a1 promoter, binds directly to the Col2a1 promoter region, and stimulates histone H3 acetylation at that region to promote chondrocyte differentiation.\",\n      \"method\": \"Co-IP (Arid5a-Sox9 interaction), ChIP, promoter reporter assays, overexpression and knockdown in chondrocytes and organ cultures\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ChIP, reporter assays, gain/loss-of-function with defined phenotype\",\n      \"pmids\": [\"21346191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Arid5a represses transcription of Ppar-γ2, thereby negatively regulating adipocyte differentiation and adipose tissue homeostasis. Loss of Arid5a leads to persistent Ppar-γ2 expression, enhanced fatty acid uptake, and adult-onset obesity; Arid5a and Ppar-γ2 are dynamically counter-regulated by each other.\",\n      \"method\": \"Arid5a KO and transgenic mice, 3T3-L1 differentiation assays, high-fat diet model, gene expression analyses\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and TG mice with defined metabolic phenotypes, gain/loss-of-function in vitro with specific molecular readouts\",\n      \"pmids\": [\"31289228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arid5a stabilizes Ido1 and Ccl2 mRNAs in tumor cells, augmenting tryptophan catabolism and creating an immunosuppressive tumor microenvironment that drives immune evasion.\",\n      \"method\": \"Arid5a deletion in tumor lines, mRNA stability assays, immunocompetent vs. immunodeficient mouse tumor models, flow cytometry of tumor microenvironment\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype plus mRNA stability assays, single study\",\n      \"pmids\": [\"34006522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-6-induced Arid5a promotes transcription of the long noncoding RNA AU021063, which in turn stabilizes Trib3 mRNA and activates Mek/Erk signaling to drive breast cancer invasion and metastasis.\",\n      \"method\": \"Arid5a genetic ablation in vitro and in vivo, reporter assays, mRNA stability assays, metastasis models\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined phenotype, mechanistic pathway established with reporter assays, single study\",\n      \"pmids\": [\"34389433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The Arid5a ARID domain uses intrinsically disordered region (IDR) extensions to modulate DNA-binding specificity and affinity, while IDRs appear crucial for RNA interactions. NMR and high-throughput in vitro binding define a consensus RNA-binding motif for the ARID domain, and iCLIP2 shows transcriptome-wide Arid5a preference for (A)U-rich regions in pre-mRNA transcripts related to RNA processing.\",\n      \"method\": \"NMR spectroscopy, high-throughput in vitro RNA binding (RBNS), iCLIP2, mutagenesis of IDR extensions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural/biochemical analysis with mutagenesis and transcriptome-wide binding, comprehensive single study\",\n      \"pmids\": [\"38866324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"IL-17 induces Arid5a nuclear export and association with 18S rRNA (a component of the 40S ribosome subunit), thereby promoting translation of C/EBPβ and C/EBPδ at the protein level rather than through mRNA stabilization, driving renal autoimmunity in autoantibody-mediated glomerulonephritis.\",\n      \"method\": \"RIP-Seq (Arid5a transcriptome-wide RNA immunoprecipitation), Arid5a KO mice, polysome/ribosome association assays, global protein synthesis assays, nuclear fractionation\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — RIP-Seq, ribosome association assays, global translation assays, KO mice with defined phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"39058386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARID5A stabilizes MAVS mRNA in cardiac cells, leading to NF-κB and TBK1 activation and amplifying cardiac aging and inflammatory phenotypes. Lentiviral shRNA targeting ARID5A in aged mouse myocardium mitigated inflammation and improved cardiac function.\",\n      \"method\": \"Human cardiac single-cell transcriptomics, mRNA stability assays, shRNA lentiviral knockdown in aged mice, NF-κB/TBK1 pathway activation assays\",\n      \"journal\": \"Nature cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mRNA stabilization with pathway activation assays and in vivo knockdown with functional readout, single study\",\n      \"pmids\": [\"40301689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Arid5a in skeletal muscle acts as a transcriptional repressor of lipid uptake genes Cd36 and Fabp4, reducing muscle triacylglycerol accumulation, as a downstream target of the glucocorticoid receptor.\",\n      \"method\": \"AAV-mediated in vivo overexpression and knockdown in muscle, GR-mutant knock-in mice, RNA-seq and ChIP-seq profiling\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain/loss-of-function with defined metabolic phenotype, ChIP-seq linking GR to Arid5a transactivation, single study\",\n      \"pmids\": [\"40632872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TNF upregulates Arid5a through the NF-κB1/TRAF2 pathway, causing its cytoplasmic relocalization. Cytoplasmic Arid5a stabilizes proinflammatory transcripts and enhances expression of chemokines driving rheumatoid arthritis. Arid5a KO mice are resistant to collagen-induced arthritis with reduced synovial Th17 cells.\",\n      \"method\": \"Traf2-/- cells, IKK/NIK inhibitors, Arid5a KO mice, collagen-induced arthritis model, mRNA stability assays, nuclear fractionation\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic (Traf2 KO) and pharmacological epistasis, Arid5a KO with defined in vivo phenotype, multiple orthogonal approaches\",\n      \"pmids\": [\"41574607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID5A stabilizes IDO1 mRNA in colorectal cancer cells, leading to tryptophan-to-kynurenine conversion that promotes CAR-T cell exhaustion via aryl hydrocarbon receptor (AhR) activation.\",\n      \"method\": \"ARID5A overexpression/knockdown in tumor cells, mRNA stability assays, co-culture with CAR-T cells, AhR/IDO1 inhibitor treatment\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mRNA stability shown, functional pathway (IDO1-kynurenine-AhR) validated with inhibitors, single study\",\n      \"pmids\": [\"38316094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Rbpjl binds to the promoter region of Arid5a and transcriptionally represses Arid5a expression, thereby suppressing the Arid5a-dependent IL-6/STAT3 signaling axis in acute pancreatitis.\",\n      \"method\": \"ChIP, EMSA, dual-luciferase reporter assays, Rbpjl overexpression/knockdown in pancreatic acinar cells, in vivo AP model\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical assays (ChIP, EMSA, reporter) establishing direct transcriptional regulation, single study\",\n      \"pmids\": [\"35725649\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARID5A is a bifunctional nucleic acid-binding protein that, upon inflammatory stimulation, translocates from the nucleus to the cytoplasm via a CRM1-dependent pathway where it stabilizes the mRNAs of key proinflammatory factors (IL-6, STAT3, T-bet, OX40, IDO1, MAVS, and others) by binding stem-loop structures in their 3'UTRs and counteracting the destabilizing endoribonucleases Regnase-1 and Roquin-1; it additionally associates with ribosomes (via 18S rRNA) to promote translation of transcription factors such as C/EBPβ, IκBζ, and C/EBPδ; upstream, it is regulated transcriptionally by NF-κB, CREB, and TLR4/MAPK signaling, and post-translationally by p38 MAPK phosphorylation followed by WWP1-mediated K48-linked ubiquitination and degradation; in the nucleus it functions as a transcriptional co-activator (partnering with Sox9 at the Col2a1 promoter) or repressor (of Ppar-γ2, Cd36, Fabp4), with its disordered ARID-flanking regions modulating nucleic acid-binding specificity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"Arid5a is an RNA-binding protein that stabilizes IL-6 mRNA by binding to its 3' untranslated region, counteracting the destabilizing effect of the ribonuclease Regnase-1, thereby promoting elevation of IL-6 serum levels in vivo.\",\n      \"method\": \"RNA binding assays, Arid5a-deficient mice, LPS challenge model, mRNA stability assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal functional assays in vitro and in vivo KO mice, replicated across multiple contexts\",\n      \"pmids\": [\"23676272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Arid5a physically interacts with Sox9 in the nucleus, binds directly to the Col2a1 gene promoter, stimulates histone H3 acetylation at that region, and cooperatively enhances chondrocyte-specific transcription and differentiation.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, overexpression and knockdown in ATDC5 cells, organ culture\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, ChIP, KD/OE with defined phenotype)\",\n      \"pmids\": [\"21346191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arid5a selectively stabilizes Stat3 mRNA (but not Stat1 or Stat5 mRNA) in CD4+ T cells in an IL-6-dependent manner, directing naive CD4+ T cells toward Th17 differentiation; loss of Arid5a reduces STAT3 levels and shifts cells toward IL-10-expressing anti-inflammatory fate.\",\n      \"method\": \"Arid5a-deficient mice, mRNA stability assays, Th17 polarization assays, flow cytometry\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined molecular and cellular phenotype, selective mRNA target specificity demonstrated\",\n      \"pmids\": [\"27022145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arid5a binds to a conserved stem-loop structure in the 3'UTR of T-bet mRNA and stabilizes it in Th1 cells, thereby promoting IFN-γ production and contributing to septic shock; Arid5a-deficient mice are resistant to LPS-induced endotoxic shock with reduced IFN-γ and IL-6.\",\n      \"method\": \"RNA binding assays (stem-loop structure), Arid5a KO mice, LPS/P. acnes endotoxic shock models, cytokine measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding to defined structural element, in vivo KO phenotype\",\n      \"pmids\": [\"27671645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"During LPS stimulation, NF-κB activates Arid5a gene expression (promoting IL-6 mRNA stabilization), while in the late phase p38 MAPK phosphorylates Arid5a and recruits the E3 ubiquitin ligase WWP1, which ubiquitinates Arid5a via K48-linked chains leading to its proteasomal degradation; additionally, AUF-1 destabilizes Arid5a mRNA via AU-rich elements in its 3'UTR.\",\n      \"method\": \"Phosphorylation assays, ubiquitination assays, NF-κB/MAPK pathway inhibitors, mutagenesis blocking phosphorylation, mRNA stability assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple PTM mechanisms identified with functional validation including mutagenesis\",\n      \"pmids\": [\"28168301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-17 signaling induces Arid5a expression; Arid5a is recruited to the adaptor TRAF2, stabilizes IL-17-induced cytokine transcripts by binding their 3'UTRs, counteracts MCPIP1 (Regnase-1)-mediated mRNA degradation, and associates with the eukaryotic translation initiation complex to facilitate translation of the transcription factors IκBζ and C/EBPβ, creating a feed-forward amplification loop.\",\n      \"method\": \"Co-immunoprecipitation (TRAF2, eIF complex), mRNA stability assays, translation assays, Arid5a KO cells\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying distinct mechanisms (mRNA stability + translation + protein complex)\",\n      \"pmids\": [\"30301788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Arid5a stabilizes OX40 mRNA in CD4+ T cells by recognizing an alternative decay element (ADE)-like stem-loop structure in the OX40 3'UTR, and impairs the RNA-destabilizing functions of both Regnase-1 and Roquin-1 on this target.\",\n      \"method\": \"RNA binding assays, stem-loop mutagenesis, Arid5a KO mice, EAE model, adoptive transfer\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding to defined structural element, multiple functional assays, in vivo validation\",\n      \"pmids\": [\"29244194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Arid5a is present in both cytoplasm and nucleus of resting cells; upon inflammatory stimulation it is imported into the nucleus via the classical importin-α/β1 pathway, and subsequently exported to the cytoplasm via CRM1-dependent nuclear export; cytoplasmic Arid5a is associated with UPF1 (up-frameshift protein 1). This stimulus-dependent nuclear-cytoplasmic shuttling is required for its dual function in mRNA stabilization and transcriptional regulation.\",\n      \"method\": \"Transgenic mice, nuclear fractionation, importin pathway inhibitors (importazole), CRM1 inhibitor (leptomycin B), co-immunoprecipitation with UPF1\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization experiments with defined pathway components and functional consequence\",\n      \"pmids\": [\"29358370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Arid5a represses transcription of Ppar-γ2, acting as a negative regulator of adipogenesis; in the absence of Arid5a, persistent Ppar-γ2 expression drives adipocyte differentiation and enhanced fatty acid uptake. Arid5a and Ppar-γ2 are dynamically counter-regulated by each other to maintain adipose tissue homeostasis.\",\n      \"method\": \"Arid5a KO mice (adult-onset obesity), Arid5a transgenic mice (diet-induced obesity resistance), 3T3-L1 differentiation assays, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and transgenic models with defined molecular mechanism, replicated in vitro and in vivo\",\n      \"pmids\": [\"31289228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arid5a stabilizes Ido1 (indoleamine 2,3-dioxygenase 1) and Ccl2 mRNAs in tumor cells, augmenting tryptophan catabolism and creating an immunosuppressive tumor microenvironment that promotes immune evasion; deletion of Arid5a in tumor cells enhances antitumor immunity in immunocompetent but not immunodeficient mice.\",\n      \"method\": \"Arid5a KO tumor cell lines, mRNA stability assays, syngeneic mouse tumor models, immune cell profiling\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined molecular targets and in vivo immune phenotype\",\n      \"pmids\": [\"34006522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-6-induced Arid5a promotes transcription of the lncRNA AU021063, which in turn stabilizes Trib3 and activates Mek/Erk signaling to drive breast cancer metastasis; genetic ablation of Arid5a abolishes this cascade.\",\n      \"method\": \"Arid5a KO, RNA stability assays, in vitro invasion assays, mouse metastasis models\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined pathway but single lab, mechanism partly indirect via lncRNA intermediate\",\n      \"pmids\": [\"34389433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MRF1 (ARID5A) binds to both the N-terminal and C-terminal regions of ERα in an estradiol-independent manner (also interacts with thyroid receptor α, RXRα, and androgen receptor in ligand-dependent manner), has intrinsic repressor activity, and represses ERα-mediated transcriptional activation in a dose-dependent manner without requiring histone deacetylase activity.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, recombinant protein binding assays, transient transfection reporter assays, GAL4 reporter assay\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding confirmed by multiple methods, functional repression validated\",\n      \"pmids\": [\"15941852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARID5A is induced by IL-6 in CD4+ T cells via a STAT3-dependent mechanism; ARID5A physically associates with RORγt through its N-terminal region and acts as a negative regulator of RORγt-induced Th17 cell differentiation and IL-17A promoter activation.\",\n      \"method\": \"Co-immunoprecipitation, overexpression in murine CD4+ T cells, IL-17A promoter reporter assay, flow cytometry\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with functional reporter assay, single lab\",\n      \"pmids\": [\"24782182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Noncanonical phosphorylation of STAT1 at Thr749 (mediated by a TBK1-IKKβ complex downstream of TLR4 endocytosis) drives STAT1 binding to a noncanonical DNA motif (5'-TTTGANNC-3') in the ARID5A promoter, thereby activating ARID5A expression and downstream IL-6 mRNA stabilization.\",\n      \"method\": \"Site-specific mutagenesis, ChIP, kinase inhibitors, TLR4 endocytosis manipulation, ARID5A promoter reporter assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis, ChIP, and functional reporter assays define a novel upstream regulatory mechanism\",\n      \"pmids\": [\"32209697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"β-catenin-mediated transcriptional activation of FOSL2 and repression of ARID5A together drive M1-to-M2 TAM polarization in lung cancer; pharmacological or genetic ablation of β-catenin reprograms M2-like TAMs to M1-like TAMs and suppresses tumor growth.\",\n      \"method\": \"Pharmacological β-catenin inhibition, macrophage-specific genetic ablation, transcriptome analysis, in vitro TAM model, in vivo lung tumor models\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological manipulation with defined pathway, but ARID5A is one of multiple effectors\",\n      \"pmids\": [\"32548260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Using NMR-centered biochemistry, the Arid5a ARID domain was found to bind DNA with a defined preference; high-throughput in vitro binding defined a consensus RNA-binding motif engaged by the core ARID domain; iCLIP2 revealed transcriptome-wide binding preference for (A)U-rich regions in pre-mRNA transcripts; intrinsically disordered regions (IDRs) flanking the ARID domain modulate DNA-binding specificity and affinity, and are crucial for RNA interactions.\",\n      \"method\": \"NMR spectroscopy, high-throughput in vitro binding (RBNS), iCLIP2, mutagenesis of IDR extensions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure, in vitro binding, transcriptome-wide mapping, and mutagenesis in one study\",\n      \"pmids\": [\"38866324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID5A stabilizes IDO1 mRNA in colorectal cancer cells, leading to upregulation of IDO1 expression, tryptophan-to-kynurenine conversion, kynurenine-mediated AhR activation in CAR-T cells, and consequent CAR-T cell exhaustion; targeting the ARID5A-IDO1-AhR axis with AhR or IDO1 inhibitors alleviates T cell exhaustion.\",\n      \"method\": \"ARID5A overexpression, mRNA stability assays, CAR-T co-culture assays, AhR/IDO1 inhibitor treatment\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — defined mechanistic axis but single lab, limited orthogonal validation\",\n      \"pmids\": [\"38316094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Transcriptome-wide RIP-Seq revealed that Arid5a inducibly interacts with IL-17 target mRNAs including CEBPB and CEBPD, as well as rRNAs including 18S rRNA (a 40S ribosome constituent); IL-17 promotes Arid5a nuclear export and association with 18S rRNA; Arid5a-deficient cells show repressed global protein synthesis, with C/EBPs controlled at the translational rather than mRNA level, establishing Arid5a as a ribosome-associated translational regulator.\",\n      \"method\": \"RIP-Seq, Arid5a KO mice, AGN mouse model, fractionation, polysome profiling, CRISPR-Cas9 KO\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transcriptome-wide RIP-Seq plus functional KO phenotype and mechanistic validation of ribosome association\",\n      \"pmids\": [\"39058386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARID5A epi-transcriptionally stabilizes MAVS (Mitochondrial Antiviral Signaling Protein) mRNA in cardiomyocytes of aged hearts, leading to NF-κB and TBK1 activation and amplifying cardiac aging and inflammation; lentiviral shRNA targeting ARID5A in aged mouse myocardium mitigated inflammatory and aging phenotypes and improved cardiac function.\",\n      \"method\": \"Single-cell RNA-seq of human heart tissues, ARID5A-MAVS RNA binding/stability assays, lentiviral shRNA gene therapy in aged mice, NF-κB/TBK1 pathway analysis\",\n      \"journal\": \"Nature cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined mRNA target with in vivo gene therapy validation, multiple methods\",\n      \"pmids\": [\"40301689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In skeletal muscle, Arid5a functions as a transcriptional repressor of the lipid uptake genes Cd36 and Fabp4, downstream of glucocorticoid receptor (GR) transactivation; Arid5a is required and sufficient to reduce muscle triacylglycerol accumulation, acting as a pro-metabolic effector.\",\n      \"method\": \"GR knock-in mice (rs6190), myotropic AAV overexpression/knockdown in muscle, RNA-seq and ChIP-seq, metabolic phenotyping\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo AAV KD/OE with defined transcriptional targets and metabolic phenotype, single lab\",\n      \"pmids\": [\"40632872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TNF upregulates Arid5a expression through the NF-κB1/TRAF2 pathway, causing cytoplasmic relocalization of Arid5a; Arid5a then stabilizes proinflammatory transcripts and enhances expression of chemokines driving rheumatoid arthritis; Arid5a-deficient mice are resistant to collagen-induced arthritis with reduced Th17 cells in synovial tissue.\",\n      \"method\": \"TRAF2 KO cells, NF-κB/IKK inhibitors, NIK inhibitors, Arid5a KO mice, collagen-induced arthritis model, mRNA stability assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined upstream pathway (TRAF2/NF-κB1), functional KO in two disease-relevant contexts\",\n      \"pmids\": [\"41574607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Rbpjl binds to the promoter region of Arid5a and transcriptionally represses its expression, thereby suppressing the Arid5a/IL-6/STAT3 signaling axis and alleviating pancreatic acinar cell inflammation in acute pancreatitis.\",\n      \"method\": \"ChIP, EMSA, dual-luciferase reporter assays, Rbpjl overexpression/knockdown, LPS-induced cell model, cerulein-induced AP mouse model\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct DNA binding of Rbpjl to Arid5a promoter confirmed by ChIP/EMSA/reporter, functional in vivo validation\",\n      \"pmids\": [\"35725649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"β2-adrenergic receptor stimulation activates the cAMP/PKA/CREB pathway in cardiac fibroblasts, phosphorylating CREB and inducing Arid5a expression; Arid5a in turn stabilizes IL-6 mRNA, and this pathway is required for β2AR-mediated IL-6 production (abolished in Arid5a KO cardiac fibroblasts).\",\n      \"method\": \"Arid5a KO cardiac fibroblasts, β2AR agonists, adenylate cyclase activators, PKA inhibitors, CREB activity assays, ELISA\",\n      \"journal\": \"Pharmacology research & perspectives\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO fibroblasts with defined upstream pathway, single lab\",\n      \"pmids\": [\"32302067\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARID5A is a bifunctional nucleic acid-binding protein that, upon inflammatory stimulation, shuttles from the nucleus to the cytoplasm (via importin-α/β1 import and CRM1-dependent export) where its ARID domain — extended by intrinsically disordered regions — binds AU-rich 3'UTR stem-loop structures to stabilize key proinflammatory mRNAs (IL-6, STAT3, T-bet, OX40, IDO1, MAVS, and others), counteracts Regnase-1/Roquin-mediated mRNA decay, associates with 18S rRNA to promote translation of targets including C/EBPβ and C/EBPδ, and is regulated by NF-κB (transcriptional induction), p38 MAPK–WWP1 (K48-ubiquitination and degradation), and AUF-1 (mRNA destabilization), while in the nucleus it acts as a transcriptional co-activator (with Sox9 at Col2a1) or repressor (of Ppar-γ2, Cd36, Fabp4) depending on cellular context.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARID5A is a bifunctional nucleic acid-binding protein that serves as a central post-transcriptional amplifier of inflammatory and metabolic gene programs. In the cytoplasm, ARID5A stabilizes mRNAs of proinflammatory mediators (IL-6, STAT3, T-bet, OX40, IDO1, MAVS) by binding stem-loop structures in their 3′UTRs and antagonizing the destabilizing endoribonucleases Regnase-1 and Roquin-1 [PMID:23676272, PMID:27671645, PMID:29244194]; it additionally associates with 18S rRNA and the translation initiation complex to promote translation of transcription factors such as C/EBPβ, C/EBPδ, and IκBζ [PMID:30301788, PMID:39058386]. Inflammatory stimulation by LPS, IL-17, or TNF triggers CRM1-dependent nuclear-to-cytoplasmic translocation of ARID5A, with its expression induced via NF-κB/TRAF2 signaling and terminated by p38 MAPK-mediated phosphorylation leading to WWP1-catalyzed K48-linked ubiquitination and proteasomal degradation [PMID:29358370, PMID:28168301, PMID:41574607]. In the nucleus, ARID5A acts as a transcriptional co-activator of Sox9 at the Col2a1 promoter in chondrocytes and as a transcriptional repressor of adipogenic (Pparγ2) and lipid-uptake (Cd36, Fabp4) genes, with its intrinsically disordered ARID-flanking regions modulating DNA- versus RNA-binding specificity [PMID:21346191, PMID:31289228, PMID:40632872, PMID:38866324].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing ARID5A as a nuclear transcriptional co-activator answered how the ARID-family protein contributes to chondrocyte gene expression: it physically partners with Sox9, binds the Col2a1 promoter, and stimulates local histone H3 acetylation.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP at Col2a1 promoter, reporter assays, gain/loss-of-function in chondrocyte cultures\",\n      \"pmids\": [\"21346191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ARID5A recruits histone acetyltransferases is not defined\",\n        \"Whether co-activator function extends to promoters beyond Col2a1 was unknown\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The discovery that ARID5A functions as an RNA-binding protein that selectively stabilizes IL-6 mRNA by antagonizing Regnase-1 fundamentally reframed the protein as a post-transcriptional regulator of inflammation, not merely a DNA-binding factor.\",\n      \"evidence\": \"RNA binding assays, mRNA half-life measurements, Arid5a-KO macrophages, LPS stimulation\",\n      \"pmids\": [\"23676272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The structural basis for selective recognition of IL-6 3′UTR versus TNF-α 3′UTR was unclear\",\n        \"Whether ARID5A stabilizes mRNAs of other inflammatory mediators was unexplored\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extension of the mRNA-stabilizing function to Stat3 and T-bet mRNAs — each with defined stem-loop 3′UTR elements — established ARID5A as a broad post-transcriptional regulator driving both Th17 (via STAT3) and Th1 (via T-bet/IFN-γ) differentiation.\",\n      \"evidence\": \"Arid5a-KO T cells with mRNA stability assays (STAT3); RNA binding to stem-loop structures and endotoxic shock model (T-bet)\",\n      \"pmids\": [\"27022145\", \"27671645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Precise RNA structural determinants distinguishing stabilized from non-stabilized transcripts were not resolved\",\n        \"How ARID5A outcompetes Regnase-1 at specific stem-loops was mechanistically unclear\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Elucidation of the complete ARID5A life-cycle during inflammation — NF-κB-driven transcriptional induction, AUF-1-mediated mRNA decay, and p38-dependent phosphorylation followed by WWP1-catalyzed K48-ubiquitination and proteasomal destruction — revealed how ARID5A protein levels are temporally gated.\",\n      \"evidence\": \"Co-IP for WWP1 interaction, phosphorylation and ubiquitination assays, mRNA stability measurements with inhibitors in macrophages\",\n      \"pmids\": [\"28168301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific phosphorylation site(s) on ARID5A targeted by p38 were not mapped\",\n        \"Whether other E3 ligases contribute to ARID5A turnover is unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three concurrent advances showed that (i) ARID5A undergoes CRM1-dependent nuclear export upon inflammatory stimulation, (ii) it stabilizes OX40 mRNA by competing with both Regnase-1 and Roquin-1 at an ADE-like stem-loop, and (iii) it associates with the eukaryotic translation initiation complex to promote translation of IκBζ and C/EBPβ downstream of IL-17, establishing a dual mRNA-stabilization/translation-promotion mechanism.\",\n      \"evidence\": \"Nuclear fractionation with CRM1/importin inhibitors and UPF1 Co-IP; OX40 mRNA stability and EAE model with KO mice; Co-IP with eIF complex, translation and mRNA stability assays\",\n      \"pmids\": [\"29358370\", \"29244194\", \"30301788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The signals triggering CRM1-dependent export were not fully delineated\",\n        \"The nature of the ARID5A–UPF1 nuclear complex function is undefined\",\n        \"Whether ribosome association and mRNA stabilization occur on overlapping or distinct target pools was unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that ARID5A represses Pparγ2 transcription to restrain adipogenesis, with Arid5a-KO mice developing adult-onset obesity, revealed a nuclear transcriptional repressor function independent of its cytoplasmic RNA-stabilizing role.\",\n      \"evidence\": \"Arid5a-KO and transgenic mice on normal/high-fat diet, 3T3-L1 adipocyte differentiation assays\",\n      \"pmids\": [\"31289228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARID5A directly binds the Pparγ2 promoter or acts through a co-repressor complex was not determined\",\n        \"The relationship between metabolic and inflammatory ARID5A functions was unexplored\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"ARID5A's mRNA-stabilizing activity was shown to operate in tumor cells — stabilizing IDO1 and CCL2 mRNAs to create an immunosuppressive microenvironment — extending its function beyond classical immune cells to cancer biology.\",\n      \"evidence\": \"ARID5A deletion in tumor cell lines, mRNA stability assays, immunocompetent vs. immunodeficient tumor models\",\n      \"pmids\": [\"34006522\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ARID5A acts on additional tumor-intrinsic transcripts beyond IDO1 and CCL2 is unknown\",\n        \"The mechanism by which tumor cells upregulate ARID5A was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Structural and transcriptome-wide analyses resolved the molecular basis of ARID5A's dual nucleic acid recognition: intrinsically disordered regions flanking the ARID domain modulate DNA- versus RNA-binding specificity, and iCLIP2 defined a preference for (A)U-rich regions in pre-mRNAs involved in RNA processing.\",\n      \"evidence\": \"NMR spectroscopy, high-throughput in vitro RNA binding (RBNS), iCLIP2, IDR mutagenesis\",\n      \"pmids\": [\"38866324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"A full-length ARID5A structure is unavailable\",\n        \"How IDR-mediated switching between DNA and RNA binding is regulated in vivo is undefined\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Direct evidence that IL-17-stimulated ARID5A associates with 18S rRNA and promotes ribosomal translation of C/EBPβ and C/EBPδ — independently of mRNA stabilization — established translational control as a distinct effector arm driving renal autoimmunity.\",\n      \"evidence\": \"RIP-Seq, polysome/ribosome association assays, global protein synthesis assays, Arid5a-KO mice with glomerulonephritis model\",\n      \"pmids\": [\"39058386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ARID5A is recruited to specific mRNAs on ribosomes versus acting globally is unclear\",\n        \"Whether the ribosome-association function is separable from 3′UTR-binding activity has not been tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extension of ARID5A's mRNA-stabilizing role to MAVS mRNA in cardiac cells and transcriptional repression of Cd36/Fabp4 in skeletal muscle demonstrated tissue-specific deployment of the same biochemical activities in aging and metabolic regulation.\",\n      \"evidence\": \"Single-cell transcriptomics, mRNA stability assays, shRNA knockdown in aged mouse myocardium (MAVS); AAV-mediated gain/loss-of-function in muscle, ChIP-seq for GR-regulated Arid5a transactivation (Cd36/Fabp4)\",\n      \"pmids\": [\"40301689\", \"40632872\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ARID5A directly binds MAVS 3′UTR stem-loop structures has not been structurally demonstrated\",\n        \"The mechanism by which ARID5A represses Cd36/Fabp4 transcription (direct DNA binding vs. co-repressor recruitment) is undefined\",\n        \"Single-study findings in cardiac aging and muscle metabolism await independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how ARID5A switches between its nuclear transcriptional and cytoplasmic post-transcriptional functions at the molecular level, what determines target selectivity among the expanding set of stabilized mRNAs, and whether the mRNA-stabilization and ribosome-associated translation-promotion activities are mechanistically coupled or independent.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No full-length structure of ARID5A in complex with RNA or DNA is available\",\n        \"The molecular basis of competitive displacement of Regnase-1/Roquin-1 is not resolved\",\n        \"Whether ARID5A functions as part of a stable ribonucleoprotein complex or acts as a transient modifier is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 3, 6, 11, 12]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 11]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [7, 8, 10, 14]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 7, 8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 5, 12, 15]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [4, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 3, 6, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 15]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 4, 11, 12]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 8, 10, 14]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 4, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"Regnase-1\",\n      \"Roquin-1\",\n      \"SOX9\",\n      \"WWP1\",\n      \"TRAF2\",\n      \"UPF1\",\n      \"AUF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ARID5A is a bifunctional nucleic acid-binding protein that acts as both a post-transcriptional regulator of proinflammatory and metabolic mRNAs and a context-dependent transcriptional co-activator or repressor. In the cytoplasm, the ARID domain—extended by intrinsically disordered regions—recognizes AU-rich stem-loop structures in the 3′UTRs of target mRNAs (IL-6, STAT3, T-bet, OX40, IDO1, MAVS), stabilizing them against Regnase-1- and Roquin-mediated decay, and associates with 18S rRNA to promote translation of targets such as C/EBPβ and C/EBPδ [PMID:23676272, PMID:27022145, PMID:27671645, PMID:29244194, PMID:39058386, PMID:40301689]. In the nucleus, ARID5A cooperates with Sox9 to activate Col2a1 transcription in chondrocytes and represses PPARγ2, CD36, and FABP4 to restrain adipogenesis and muscle lipid uptake [PMID:21346191, PMID:31289228, PMID:40632872]. ARID5A expression is induced by NF-κB, noncanonical pSTAT1, and CREB, while its turnover is governed by p38 MAPK-dependent phosphorylation and WWP1-mediated K48-linked ubiquitination; stimulus-dependent nuclear–cytoplasmic shuttling via importin-α/β1 import and CRM1-dependent export enables its dual functions [PMID:28168301, PMID:29358370, PMID:32209697].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Before its RNA-binding role was recognized, ARID5A (MRF1) was identified as a nuclear receptor corepressor, establishing that it directly interacts with ERα and other nuclear receptors to repress transcription independently of HDACs.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, and reporter assays in transfected cells\",\n      \"pmids\": [\"15941852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Endogenous target genes of the ERα–ARID5A repressor complex were not identified\",\n        \"In vivo relevance of nuclear receptor corepression was not tested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery of ARID5A as a transcriptional co-activator of Sox9 at the Col2a1 promoter revealed that its nuclear function is context-dependent—activating or repressing transcription depending on partner factors.\",\n      \"evidence\": \"Co-IP with Sox9, ChIP at Col2a1, overexpression/knockdown in ATDC5 chondrocytes\",\n      \"pmids\": [\"21346191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARID5A binds Col2a1 DNA directly via its ARID domain or is recruited indirectly through Sox9 was not resolved\",\n        \"Genome-wide transcriptional co-activator targets in chondrocytes were not mapped\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The landmark finding that ARID5A stabilizes IL-6 mRNA by binding its 3′UTR and antagonizing Regnase-1 reframed the protein as a post-transcriptional immune regulator, explaining its requirement for elevated IL-6 during endotoxemia.\",\n      \"evidence\": \"RNA binding assays, Arid5a-deficient mice, LPS challenge, mRNA stability assays\",\n      \"pmids\": [\"23676272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the 3′UTR interaction was unknown\",\n        \"Full repertoire of stabilized mRNAs remained undefined\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extension of the mRNA stabilization paradigm to STAT3 and T-bet mRNAs demonstrated that ARID5A selectively governs Th17 and Th1 differentiation programs by stabilizing lineage-defining transcription factor transcripts.\",\n      \"evidence\": \"Arid5a KO Th17/Th1 polarization assays, stem-loop binding, LPS/P. acnes septic shock models\",\n      \"pmids\": [\"27022145\", \"27671645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ARID5A discriminates STAT3 from STAT1/STAT5 mRNAs at the structural level was not defined\",\n        \"Relative contribution of Th17 vs Th1 arm in autoimmunity was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of the NF-κB–driven induction and p38 MAPK/WWP1-mediated K48-ubiquitination of ARID5A established the negative feedback loop that terminates its activity during the late phase of inflammation.\",\n      \"evidence\": \"Phosphorylation/ubiquitination assays, mutagenesis, NF-κB/MAPK inhibitors, AUF-1 mRNA decay\",\n      \"pmids\": [\"28168301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific p38-phosphorylated residues on ARID5A were not mapped at single-site resolution\",\n        \"Whether other E3 ligases contribute to ARID5A turnover was not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three simultaneous advances broadened ARID5A's mechanism: (i) nuclear–cytoplasmic shuttling via importin-α/β1 and CRM1 was shown to be required for its dual functions; (ii) OX40 mRNA was identified as a target stabilized against both Regnase-1 and Roquin; (iii) ARID5A was found to associate with the translation initiation machinery to promote C/EBPβ translation downstream of IL-17.\",\n      \"evidence\": \"Importin/CRM1 inhibitors in transgenic mice; stem-loop mutagenesis and EAE model; TRAF2 co-IP and polysome association\",\n      \"pmids\": [\"29358370\", \"29244194\", \"30301788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ARID5A engages the translation initiation complex mechanistically (direct vs indirect) was not resolved\",\n        \"Identity of UPF1 interaction's functional consequence remained unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that ARID5A represses PPARγ2 transcription to restrain adipogenesis extended its nuclear repressor function to metabolic homeostasis, with knockout mice developing adult-onset obesity.\",\n      \"evidence\": \"Arid5a KO (obesity) and transgenic (obesity resistance) mice, 3T3-L1 differentiation\",\n      \"pmids\": [\"31289228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARID5A directly binds PPARγ2 regulatory DNA or acts through a cofactor complex was not determined\",\n        \"Interaction with chromatin-modifying enzymes at adipogenic loci was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Upstream regulation of ARID5A was further defined: noncanonical pSTAT1-Thr749 binds a novel motif in the ARID5A promoter downstream of TLR4 endocytosis, and β2-adrenergic/CREB signaling induces ARID5A in cardiac fibroblasts, revealing tissue-specific transcriptional control.\",\n      \"evidence\": \"ChIP, site-directed mutagenesis, ARID5A promoter reporters; β2AR agonists and PKA inhibitors in Arid5a KO fibroblasts\",\n      \"pmids\": [\"32209697\", \"32302067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether pSTAT1-Thr749 and NF-κB cooperate at the ARID5A promoter simultaneously was not tested\",\n        \"In vivo cardiac phenotype of ARID5A induction via β2AR was not examined\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"ARID5A's role in tumor immune evasion was established: it stabilizes IDO1 and CCL2 mRNAs in tumor cells, promoting tryptophan catabolism and immunosuppression; separately, it activates transcription of a lncRNA driving breast cancer metastasis.\",\n      \"evidence\": \"Arid5a KO tumor lines in syngeneic models with immune profiling; Arid5a KO with metastasis assays\",\n      \"pmids\": [\"34006522\", \"34389433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARID5A's mRNA stabilization vs transcriptional activation roles can be pharmacologically uncoupled was not explored\",\n        \"Generalizability across cancer types beyond melanoma, colon, and breast was not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Structural and transcriptome-wide studies resolved how ARID5A recognizes nucleic acids: NMR defined ARID domain–DNA contacts, RBNS/iCLIP2 identified a consensus AU-rich RNA motif, and IDRs flanking the ARID domain were shown to be essential for RNA binding; simultaneously, RIP-Seq and polysome profiling established ARID5A as a ribosome-associated translational regulator via 18S rRNA interaction.\",\n      \"evidence\": \"NMR, RBNS, iCLIP2, IDR mutagenesis; RIP-Seq, polysome profiling in Arid5a KO mice\",\n      \"pmids\": [\"38866324\", \"39058386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-resolution structure of ARID5A bound to an RNA stem-loop is still lacking\",\n        \"How 18S rRNA association promotes translation of specific mRNAs over others is mechanistically unresolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"ARID5A's target repertoire was extended to cardiac aging (MAVS mRNA stabilization) and skeletal muscle lipid metabolism (transcriptional repression of CD36/FABP4), demonstrating that its dual nuclear/cytoplasmic functions operate across diverse non-immune tissues.\",\n      \"evidence\": \"scRNA-seq of human hearts, ARID5A shRNA gene therapy in aged mice; GR knock-in mice, myotropic AAV OE/KD with ChIP-seq\",\n      \"pmids\": [\"40301689\", \"40632872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARID5A-MAVS stabilization contributes to non-cardiac aging tissues remains untested\",\n        \"Structural basis of ARID5A's dual DNA-repressor vs mRNA-stabilizer selectivity is undefined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic structure of ARID5A in complex with RNA stem-loops, the mechanism by which ribosome association selectively enhances translation of specific targets, and whether the transcriptional and post-transcriptional functions can be pharmacologically dissected for therapeutic intervention.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution co-crystal or cryo-EM structure of ARID5A bound to RNA\",\n        \"Selectivity mechanism for ribosome-associated translational enhancement is unknown\",\n        \"No small-molecule inhibitors of ARID5A have been reported\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 3, 5, 6, 9, 15, 16, 17, 18]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 8, 15, 19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 8, 11, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 17]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [5, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 7, 8, 11, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 7, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 3, 6, 9, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 8, 10, 11, 19]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 2, 3, 5, 15, 17, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 13, 14, 22]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [8, 9, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"REGNASE1\",\n      \"SOX9\",\n      \"WWP1\",\n      \"TRAF2\",\n      \"UPF1\",\n      \"ROQUIN1\",\n      \"ESRA\",\n      \"RORGC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}